Details

Last Funding Type

Series Unknown

Last Funding Money Raised

€500K

Industries

Biotechnology,Health Care,Wellness

Founded date

Jul 1, 2015

Number Of Employee

1 - 10

Operating Status

Active

Betalin Therapeutics is a privately-held company. We develop a cell therapy solution for insulin-dependent diabetes, an Engineered Micro-Pancreas (EMP). The EMP is a combination of harvested pancreatic islets (also known as Islets of Langerhans) and a proprietary biological micro-environment for supporting the harvested cells.

After promising in-vitro results and preliminary in-vivo results, Betalin Therapeutics is currently putting efforts to further optimize the therapy in animal models, complete submission of the Investigational New Drug (IND) application to the FDA, and proceed to clinical trials.